Diabetes is a relatively common and easily managed condition, but for many patients monitoring insulin intake remains an arduous and irritating task. So what is being done to help make this easier for patients? We take a look at ways that technology is being used to make improve diabetes care. Plus, we speak to industry insiders to uncover the most important factors to think about when choosing a contract manufacturer.
Also, we take a look at the legitimacy of femtech innovations and the companies looking to tap into the lucrative field of fertility treatments, debate the benefits and challenges of using Amazon’s Alexa voice assistant to bring NHS-certified medical information to patients in their own homes, and examine the potential of Heartflow Analysis, which uses data from CAT scans to generated a 3D model of a patient’s heart.
Plus, we find out how innovations in neurotechnology-based therapies are benefiting patients, delve into the virtual world of prescription video games with the team behind Akili Interactive’s immersive product that is said to help to treat and manage ADHD, and get the inside scoop on med tech investment funds with life sciences venture capital fund Vesalius Biocapital.
In this issue
Future diabetes care: deep brain stimulation and implanted insulin
Diabetes is a common condition which can be easily managed, but monitoring insulin intake can still be a constant hassle. Now, French start-up Diabeloop has developed a system which combines machine learning with a continuous glucose monitor and an insulin pump to automate the process. How exactly does the tech work, what other innovations are taking place in the field of diabetes care? Chloe Kent reports.
Roundtable: choosing a contract device manufacturer
Medical device contract manufacturing is a rapidly growing sector, with the market expected to reach a value of more than $91bn by 2024 from just $55bn in 2019. But for medical device firms considering outsourcing the manufacturing of their devices to a contract operator, what are the biggest risks and rewards? Chloe Kent gets insider insight from key industry figures.
Cashing in on fertility: should femtech receive more scrutiny?
Femtech is awash with new apps, monitors and devices claiming to increase the user’s chances of having a baby by tracking their fertile window with pinpoint accuracy. While increased ovulatory awareness helping couples conceive is a given, can these tools really deliver the results they’re promising? Chloe Kent finds out.
Debate: can Alexa be trusted with our health questions?
In July, the UK National Health Service announced it has teamed up with Amazon to make NHS-verified health information searchable by voice on the company’s Alexa home assistant. The move could make it easier for users to access reliable answers to their questions, but does this come at a cost? Chloe Kent and Chris Lo lay out the arguments for and against this digital partnership.
HeartFlow Analysis: a better way to diagnose heart disease?
A technology called HeartFlow Analysis has been rolled out by the NHS to aid the diagnosis of coronary heart disease. Using data captured by a CT scan, it generates a 3D model of a patient’s heart, and applies deep learning techniques to predict the impact of any blockages. Abi Millar spoke to HeartFlow’s founder to find out its benefits.
The promise of neurotechnology
Neurotechnology-based therapies, including brain-machine interfaces, robotics, and brain stimulation, have been touted as potential game-changers for people with neurological disorders. Abi Millar takes a look at the state of neurotechnology, and how innovative treatments are already benefitting patients.
Ready player one: booting up the prescription video game
Akili Interactive is developing a range of ‘prescription video games’ that combine specialised algorithms with cutting-edge gaming tech to improve cognitive function in various patient groups with neurological disorders. How exactly does this form of digital therapy work, and what is the potential for engaging game experiences to deliver cognitive benefits? Chris Lo reports.
An inside look at medtech venture capital with VESALIUS
Life sciences venture capital fund Vesalius Biocapital has recently closed its third and largest fund, marking a move towards digital health from drug development and securing funding from the European Investment Fund for the first time. Chloe Kent spoke to Vesalius about what this funding means for the company.
Next issue preview
In the next issue of Medical Technology we take a look at the role of home sperm testing in the fertility market, find out how gaming technology is being used to train astronauts how to treat medical issues and examine the dirty problem of sterilising duodenoscopes.
Also, we learn about a smartphone-controlled implant that can deliver light and drugs to the brain, explore how tech is being used to target challenges in at-home management of asthma, and speak to Nottingham University professor Barrie Hayes-Gill about building neonatal and foetal monitoring devices.
Plus, industry experts give their view of the NHS’s newly launched AI lab, we roundup the core challenges facing 3D printed organs, and, as always, we get the latest insight and analysis from GlobalData experts.